CV - CapsoVision, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

CAPSOVISION, INC.

NASDAQ

$5.93

▼ DOWN 2.15% (-0.13)

KEY STATISTICS

Market Cap$296.28 M

52w High$15.37

52w Low$3.43

Dividend Yield—

Frequency—

P/E-2.37

Volume83.03K

Shares Out.49.96M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Kang-Huai Wang

COMPENSATION 2026

Salary$250,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$0

Total$250,000

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 2, 2025

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

PRICE TARGET

Target High$9.00

Target Low$9.00

Target Median$9.00

Target Consensus$9.00

UPCOMING EARNINGS

DateNov 12, 2026

DayThursday

Rev. Est.$3.74M

NOV

THU

PRICE

$5.93 ▼ DOWN 2.15% (−$0.13)

About CapsoVision, Inc.

https://capsovision.com ↗

CapsoVision, Inc. develops and markets capsule endoscopy devices and cloud-based software for gastrointestinal imaging, serving medical practices, clinics, and hospitals worldwide.

INDUSTRY

Medical - Devices

A PRODUCT CAPSOVISION, INC. IS KNOWN FOR

CapsoCam Plus

CapsoCam Plus is a capsule endoscopy system providing high-resolution, 360° panoramic images of the small bowel, allowing patients to ingest it for comfortable, recorder-free detection of abnormalities.